PATENT CLAIM ANALYSIS

Application Number: 15762108
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "186100"]

Abstract:
The subject invention concerns methods and materials for inducing an immune response in an animal or person against an immunodeficiency virus, such as HIV, SIV, or FIV. In one embodiment, a method of the invention comprises administering one or more antigens and/or immunogens to the person or animal wherein the antigen and/or immunogen comprises one or more evolutionarily conserved epitopes of immunodeficiency viruses. In one embodiment, the epitope is one that is conserved between HIV and FIV.

Claim (Index 67):
The method according to  claim 61 , wherein said cytotoxins, cytolysins, and/or cytokines are one or more of IL2, IFN\u03b3, tumor necrosis factor \u03b1 (TNF\u03b1), perforin, or granzyme A or B.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 95.0
- Lexical Diversity: 1.66667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14617711', '11326062', '12407730', '10408701', '10636079']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7741615009561513
- 35 USC 102 Novelty (BERT): 0.5982012167474151
- Combined Prediction Score: 0.7565654725352777
- Mean Citation Score: 471.1492420000001
- Max Citation Score: 695.04443
- Similarity Product: 406.2596937905664

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test